Latest News

- Municipal support for the DZNE information campaign for brain research in Magdeburg

Standortsprecher und Oberbürgermeister präsentieren die Kampagne

The DZNE in Magdeburg is launching a city-wide information campaign.

Read more

- Together against dementia: 10 years of DZNE

Gruppenbild

The DZNE celebrated its tenth anniversary with a ceremonial act.

Read more

- DZNE scientists funded for Parkinson’s research through EU Innovative Medicines Initiative

EU Flagge

About half a million euros approved for research into the ‘powerhouses’ of cells.

Read more

- Lab study: Parkinson’s researchers test a new approach against motor disorders

Neuronen

DZNE scientists have been able to alleviate motor disorders in mice that resemble those seen in Parkinson’s patients.

Read more

- Dementia research: 100,000 euros for transatlantic collaboration

Gruppenfoto

Sabina Tahirovic, vom DZNE in München, und Susan Cotman, vom Massachusetts General Hospital in Boston, erhalten den „Neurodegeneration Research Award“. Mit dem Preisgeld wollen sie Gemeinsamkeiten von Demenzerkrankungen bei Kindern und Erwachsenen erforschen.

Read more

- Researching Memory with mobile Apps

Foto der neotiv-APP

With the help of a free app everyone can now contribute to the research of cognition.

Read more

- Roger de Spoelberch Prize goes to DZNE Neuroscientist

Prof. Frank Bradke

Frank Bradke to be awarded for research on neuronal regeneration.

Read more

- Early Prediction of Alzheimer’s Progression in Blood

Symbolbild Blutzellen

DZNE scientists show that a protein found in the blood can be used to precisely monitor disease progression of Alzheimer’s long before first clinical signs appear.

Read more

- Europe looks to cells for a healthier future

EU supports the international LifeTime consortium in which the DZNE is involved.

Read more

- Defective immune cells in the brain cause Alzheimer’s disease

DZNE scientists shed light on the reasons why the TREM2 gene is so important for brain health. Their study is published in the journal “Nature Neuroscience” and has important implications for the development of new drugs.

Read more

Info-Hotline

Thursdays 1:30-4:30 pm

Patients +49 800-7799001

(free of charge)

Professionals +49 180-779900

(9 Cent/Min. German landline, mobile and out of Germany possibly more expensive)